Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 13, 2014Journal of Clinical Oncology

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAntonio SalarInstitució Catalana de Recerca i Estudis AvançatsIAIrit AviviTel Aviv Sourasky Medical CenterBBBeate BittnerRoche (Switzerland)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Salar et al. (2014) studied this question.

synapsesocial.com/papers/6a85adfc4f2eb4dbc91e69bdhttps://doi.org/10.1200/jco.2013.52.2631
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte2010 · 1,590 citations
  2. 2Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD201994 · 1,948 citations
  3. 3Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial2006 · 593 citations
  4. 4CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma2002 · 5,634 citations
  5. 5Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study2009 · 279 citations